MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency

Journal of Experimental Medicine

Volumn 205, Issue 11, 2008, Pages 2673-2682

  Godet, Yann ^a   Moreau Aubry, Agnès ^a,b   Guilloux, Yannik ^a,b   Vignard, Virginie ^a   Khammari, Amir ^a,c   Dreno, Brigitte ^a,c   Jotereau, Francine ^a,b   Labarriere, Nathalie ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN MELOE 1; COMPLEMENTARY DNA; HLA A2 ANTIGEN; UNCLASSIFIED DRUG; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; MELOE 1 ANTIGEN, HUMAN; MELOE-1 ANTIGEN, HUMAN; OLIGONUCLEOTIDE; PRIMER DNA; TUMOR ANTIGEN; TUMOR PROTEIN;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER RELAPSE; CELL SELECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA LIBRARY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MELANOCYTE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; METABOLISM; RECURRENT DISEASE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; NEOPLASM PROTEINS; OLIGONUCLEOTIDES; RECURRENCE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 58149153043     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081356     Document Type: Article

References (38)

1. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6462.
2. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643-1647.
3. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by au- tologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
4. Wolfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wolfel, E. Klehmann- Hieb, E. De Plaen, T. Hankeln, K.H. Meyer zum Buschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269: 1281-1284.
5. Kessler, J.H., N.J. Beekman, S.A. Bres-Vloemans, P. Verdijk, P.A. van Veelen, A.M. Kloosterman-Joosten, D.C. Vissers, G.J. ten Bosch, M.G. Kester, A. Sijts, et al. 2001. Efficient identification of novel HLA- A(*)0201- presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med. 193:73-88.
6. Guilloux, Y., S. Lucas, V.G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethe, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransfer- ase V gene. J. Exp. Med. 183:1173-1183.
7. + T cell clone on melanoma. J. Exp. Med. 191:1617-1624.
8. Jager, E., M. Maeurer, H. Hohn, J. Karbach, D. Jager, Z. Zidianakis, A. Bakhshandeh-Bath, J. Orth, C. Neukirch, A. Necker, et al. 2000. Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int. J. Cancer. 86:538-547.
9. Jager, E., H. Hohn, A. Necker, R. Forster, J. Karbach, K. Freitag, C. Neukirch, C. Castelli, R.D. Salter, A. Knuth, and M.J. Maeurer. 2002. Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1. Int. J. Cancer. 98:376-388.
10. Dudley, M.E., J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, et al. 2002. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 298:850-854.
11. Mackensen, A., N. Meidenbauer, S. Vogl, M. Laumer, J. Berger, and R. Andreesen. 2006. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J. Clin. Oncol. 24:5060-5069.
12. Meidenbauer, N., J. Marienhagen, M. Laumer, S. Vogl, J. Heymann, R. Andreesen, and A. Mackensen. 2003. Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J. Immunol. 170:2161-2169.
13. Vignard, V., B. Lemercier, A. Lim, M.C. Pandolfino, Y. Guilloux, A. Khammari, C. Rabu, K. Echasserieau, F. Lang, M.L. Gougeon, et al. 2005. Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells. J. Immunol. 175:4797-4805.
14. Benlalam, H., V. Vignard, A. Khammari, A. Bonnin, Y. Godet, M.C. Pandolfino, F. J otereau, B. Dreno, and N. Labarriere. 2007. I nfusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients. Cancer Immunol. Immunother. 56:515-526.
15. Yee, C., J.A. Thompson, D. Byrd, S.R. Riddell, P. Roche, E. Celis, and P.D. Greenberg. 2002. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. USA. 99:16168-16173.
16. Dreno, B., J.M. Nguyen, A. Khammari, M.C. Pandolfino, M.H. Tessier, S. Bercegeay, A. Cassidanius, P. Lemarre, S. Billaudel, N. Labarriere, and F. Jotereau. 2002. Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol. Immunother. 51:539-546.
17. Labarriere, N., M.C. Pandolfino, N. Gervois, A. Khammari, M.H. Tessier, B. Dreno, and F. Jotereau. 2002. Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients. Cancer Immunol. Immunother. 51:532-538.
18. Khammari, A., J.M. Nguyen, M.C. Pandolfino, G. Quereux, A. Brocard, S. Bercegeay, A. Cassidanius, P. Lemarre, C. Volteau, N. Labarriere, et al. 2007. Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol. Immunother. 56:1853-1860.
19. Benlalam, H., N. Labarriere, B. Linard, L. Derre, E. Diez, M.C. Pandolfino, M. Bonneville, and F. Jotereau. 2001. Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy. Eur. J. Immunol. 31:2007-2015.
20. Godefroy, E., A. Moreau-Aubry, E. Diez, B. Dreno, F. J otereau, and Y. Guilloux. 2005.
21. Mammalian Gene Collection Program Team. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA. 99:16899-16903.
22. Venter, J.C., M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, G.G. Sutton, H.O. Smith, M. Yandell, C.A. Evans, R.A. Holt, et al. 2001. The sequence of the human genome. Science. 291:1304-1351.
23. Labarriere, N., N. Gervois, A. Bonnin, R. Bouquie, F. Jotereau, and F. Lang. 2008. PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting. Cancer Immunol. Immunother. 57:185-195.
24. Grozinger, C.M., C.A. Hassig, and S.L. Schreiber. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA. 96:4868-4873.
25. Boon, T., P.G. Coulie, B.J. Van den Eynde, and P. van der Bruggen. 2006. Human T cell responses against melanoma. Annu. Rev. Immunol. 24:175-208.
26. Coulie, P.G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
27. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
28. Savage, P.A., K. Vosseller, C. Kang, K. Larimore, E. Riedel, K. Wojnoonski, A.A. Jungbluth, and J.P. Allison. 2008. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science. 319:215-220.
29. De Smet, C., A. Loriot, and T. Boon. 2004. Promoter-dependent mechanism leading to selective hypomethylation within the 5 ' region of gene MAGE-A1 in tumor cells. Mol. Cell. Biol. 24:4781-4790.
30. Du, J., A.J. Miller, H.R. Widlund, M.A. Horstmann, S. Ramaswamy, and D.E. Fisher. 2003. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am. J. Pathol. 163:333-343.
31. Bentley, N.J., T. Eisen, and C.R. Goding. 1994. Melanocyte-specific expression of the human tyrosinase promoter: activation by the micro- phthalmia gene product and role of the initiator. Mol. Cell. Biol. 14: 7996-8006.
32. Pandolfino, M.C., N. Labarriere, M.H. Tessier, A. Cassidanius, S. Bercegeay, P. Lemarre, F. Dehaut, B. Dreno, and F. Jotereau. 2001. High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement. Cancer Immunol. Immunother. 50:134-140.
33. Jotereau, F., M.C. Pandolfino, D. Boudart, E. Diez, B. Dreno, J.Y. Douillard, J.Y. Muller, and B. LeMevel. 1991. High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy. J. Immunother. 10:405-411.
34. Gervois, N., N. Labarriere, S. Le Guiner, M.C. Pandolfino, J.F. Fonteneau, Y. Guilloux, E. Diez, B. Dreno, and F. Jotereau. 2000. High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide- pulsed melanoma cells. Clin. Cancer Res. 6:1459-1467.
35. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
36. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection ofintracellular cytokines by flow cytometry.J. Immunol. Methods. 159:197-207.
37. Pfaffl, M.W., I.G. Lange, A. Daxenberger, and H.H. Meyer. 2001. Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR. APMIS. 109:345-355.
38. Bodinier, M., M.A. Peyrat, C. Tournay, F. Davodeau, F. Romagne, M. Bonneville, and F. Lang. 2000. Efficient detection and immuno- magnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 6:707-710.